1
|
Zhang XM, Xu KL, Kong JH, Dong G, Dong SJ, Yang ZX, Xu SJ, Wang L, Luo SY, Zhang YD, Zhou CC, Gu WY, Mei SY. Heterozygous CAPZA2 mutations cause global developmental delay, hypotonia with epilepsy: a case report and the literature review. J Hum Genet 2024; 69:197-203. [PMID: 38374166 DOI: 10.1038/s10038-024-01230-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 02/05/2024] [Accepted: 02/06/2024] [Indexed: 02/21/2024]
Abstract
CAPZA2 encodes the α2 subunit of CAPZA, which is vital for actin polymerization and depolymerization in humans. However, understanding of diseases associated with CAPZA2 remains limited. To date, only three cases have been documented with neurodevelopmental abnormalities such as delayed motor development, speech delay, intellectual disability, hypotonia, and a history of seizures. In this study, we document a patient who exhibited seizures, mild intellectual disability, and impaired motor development yet did not demonstrate speech delay or hypotonia. The patient also suffered from recurrent instances of respiratory infections, gastrointestinal and allergic diseases. A novel de novo splicing variant c.219+1 G > A was detected in the CAPZA2 gene through whole-exome sequencing. This variant led to exon 4 skipping in mRNA splicing, confirmed by RT-PCR and Sanger sequencing. To our knowledge, this is the third study on human CAPZA2 defects, documenting the fourth unambiguously diagnosed case. Furthermore, this splicing mutation type is reported here for the first time. Our research offers additional support for the existence of a CAPZA2-related non-syndromic neurodevelopmental disorder. Our findings augment our understanding of the phenotypic range associated with CAPZA2 deficiency and enrich the knowledge of the mutational spectrum of the CAPZA2 gene.
Collapse
Affiliation(s)
- Xiao-Man Zhang
- Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Kai-Li Xu
- Department of Pediatric Neurology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Jing-Hui Kong
- Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Geng Dong
- Department of Clinical Laboratory, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Shi-Jie Dong
- Department of Radiology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Zhi-Xiao Yang
- Department of Pediatric Neurology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Shu-Jing Xu
- Department of Pediatric Neurology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Li Wang
- Department of Pediatric Neurology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Shu-Ying Luo
- Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Yao-Dong Zhang
- Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Chong-Chen Zhou
- Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China
| | - Wei-Yue Gu
- Chigene Translational Medical Research Center Co. Ltd, Beijing, China
| | - Shi-Yue Mei
- Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China.
| |
Collapse
|
2
|
Li G, Sun Q, Fu Y, Hou S, Zhang J, Xu KL, Dai JY. A single crystal row-column-array for 3D ultrasound imaging. Ultrasonics 2024; 139:107289. [PMID: 38492351 DOI: 10.1016/j.ultras.2024.107289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/01/2023] [Revised: 03/03/2024] [Accepted: 03/03/2024] [Indexed: 03/18/2024]
Abstract
In vivo 3D ultrasound imaging with 2D-array transducers is of great importance for both clinical application and biomedical research, but it is complicated in fabrication and also very expensive in hardware due to thousands of electronic channels. In this work, we demonstrate a new fabrication process of 7-MHz 128 + 128 elements row-column-array (RCA) transducer with relaxor ferroelectric PMN-0.28PT single crystal. With piezoelectric single crystal and improved acoustic matching, the optimized performance of -6 dB bandwidth of ∼82 % and insertion loss of -44.6 dB is achieved. The axial and lateral imaging resolutions at different depth of the RCA transducer are quantified by the point spread function (PSF), and the results are respectively 0.20 mm and 0.41 mm at the depth of 7.7 mm, and 0.22 mm and 0.47 mm at the depth of 16.7 mm. The transducer is validated experimentally on a hyperechoic phantom, and 3D view and slices of B-mode images are obtained. The experimental results indicate that our developed RCA transducer can obtain high-quality 3D ultrasound images, demonstrating great potential on ultrafast 3D and functional imaging.
Collapse
Affiliation(s)
- Guo Li
- Department of Applied Physics, The Hong Kong Polytechnic University, Hong Kong, China; School of Automation, Xi'an University of Posts &Telecommunications, Xi'an, China.
| | - Qiandong Sun
- Department of Biomedical Engineering, Fudan University, Shanghai, China
| | - Yapeng Fu
- Department of Biomedical Engineering, Fudan University, Shanghai, China
| | - Shilin Hou
- Department of Applied Physics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Jiaming Zhang
- Department of Applied Physics, The Hong Kong Polytechnic University, Hong Kong, China
| | - K L Xu
- Department of Biomedical Engineering, Fudan University, Shanghai, China; Shanghai Poda Medical Technology Co., Ltd., Shanghai, China.
| | - J Y Dai
- Department of Applied Physics, The Hong Kong Polytechnic University, Hong Kong, China.
| |
Collapse
|
3
|
Dong HR, Yu JJ, Chen XY, Xu KL, Xie R. [Application of super-resolution and ultrafast ultrasound to reveal the characteristics of vascular blood flow changes after rat spinal cord injury at different segments]. Zhonghua Yi Xue Za Zhi 2024; 104:690-694. [PMID: 38418168 DOI: 10.3760/cma.j.cn112137-20231020-00830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/01/2024]
Abstract
Objective: To investigate the changes of spinal vascular blood flow in SD rats after cervical, thoracic and lumbar spinal cord injury (SCI) using super-resolution ultrafast ultrasound technology. Methods: A total of 9 SD rats were used to construct SCI models at different segments using a 50 g aneurysm clip. Super-resolution ultrafast ultrasound technology was used to perform vascular blood flow imaging on the spinal cord of rats before and after injury at 6 hours, obtaining quantitative information such as spinal cord vascular density and blood flow velocity. Results: Ultrasound imaging showed that after SCI, the vascular density in the thoracic segment decreased (18.16%±1.04%) more than in the cervical segment (11.42%±1.39%) and lumbar segment (13.88%±1.43%, both P<0.05). The length of the spinal cord with decreased vascular density in the thoracic segment [(4.80±0.34)mm] was longer than that in the cervical segment [(2.80±0.57)mm] and lumbar segment [(3.10±0.36)mm, both P<0.05]. After injury, the decrease of blood flow in the thoracic segment [(8.87±0.85)ml/min] was higher than that in the cervical segment [(4.88±0.56)ml/min] and lumbar segment [(6.19±0.71)ml/min, both P<0.05]. HE staining and Nissl staining showed that the proportion of cavity area after thoracic SCI (11.53%±0.93%) was higher than that in the cervical segment (4.90%±1.72%) and lumbar segment (7.64%±0.84%, both P<0.05). The number of Nissl bodies in the thoracic segment (18.0±5.3) was also lower than that in the cervical segment (32.3±5.1) and lumbar segment (37.0±5.6) (both P<0.05). Conclusions: There are different changes in vascular blood flow after SCI in different segments of rats. The same injury causes the most severe damage to blood vessels in the thoracic spinal cord, followed by the lumbar spinal cord, and the cervical spinal cord has the least damage.
Collapse
Affiliation(s)
- H R Dong
- Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - J J Yu
- School of Information Science and Engineering, Fudan University, Biomedical Engineering Center, Shanghai 200438, China
| | - X Y Chen
- Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - K L Xu
- School of Information Science and Engineering, Fudan University, Biomedical Engineering Center, Shanghai 200438, China
| | - R Xie
- Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China
| |
Collapse
|
4
|
Sun Q, Qi YK, Qi KM, Yan ZL, Cheng H, Chen W, Zhu F, Sang W, Li DP, Cao J, Shi M, Li ZY, Xu KL. [Observation of liver indexes in patients with relapsed/refractory multiple myeloma treated with CAR-T-cells based on BCMA]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:832-837. [PMID: 38049335 PMCID: PMC10694074 DOI: 10.3760/cma.j.issn.0253-2727.2023.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Indexed: 12/06/2023]
Abstract
Objective: To observe the characteristics of the evolution of liver indexes in patients with relapsed/refractory multiple myeloma (RRMM) treated with CAR-T-cells based on BCMA. Methods: Retrospective analysis was performed of patients with RRMM who received an infusion of anti-BCMA CAR-T-cells and anti-BCMA combined with anti-CD19 CAR-T-cells at our center between June 1, 2019, and February 28, 2023. Clinical data were collected to observe the characteristics of changes in liver indexes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and direct bilirubin (DBIL) in patients, and its relationship with cytokine-release syndrome (CRS) . Results: Ninety-two patients were included in the analysis, including 41 patients (44.6%) in the group receiving a single infusion of anti-BCMA CAR-T-cells, and 51 patients (55.4%) in the group receiving an infusion of anti-BCMA combined with anti-CD19 CAR-T-cells. After infusing CAR-T-cells, 31 patients (33.7%) experienced changes in liver indexes at or above grade 2, which included 20 patients (21.7%) with changes in one index, five patients (5.4%) with changes in two indexes, and six patients (6.5%) with changes in three or more indexes. The median time of peak values of ALT and AST were d17 and d14, respectively, and the median duration of exceeding grade 2 was 5.0 and 3.5 days, respectively. The median time of peak values of TBIL and DBIL was on d19 and d21, respectively, and the median duration of exceeding grade 2 was 4.0 days, respectively. The median time of onset of CRS was d8, and the peak time of fever was d9. The ALT, AST, and TBIL of patients with CRS were higher than those of patients without CRS (P=0.011, 0.002, and 0.015, respectively). CRS is an independent factor that affects ALT and TBIL levels (OR=19.668, 95% CI 18.959-20.173, P=0.001). The evolution of liver indexes can be reversed through anti-CRS and liver-protection treatments, and no patient died of liver injury. Conclusions: In BCMA-based CAR-T-cell therapy for RRMM, CRS is an important factor causing the evolution of liver indexes. The evolution of liver indexes after CAR-T-cell infusion is transient and reversible after treatment.
Collapse
Affiliation(s)
- Q Sun
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - Y K Qi
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - K M Qi
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - Z L Yan
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - H Cheng
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - W Chen
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - F Zhu
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - W Sang
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - D P Li
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - J Cao
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - M Shi
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - Z Y Li
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| | - K L Xu
- Hematology Institute of Xuzhou Medical University, Hematology Department of The Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Key Laboratory of Bone Marrow Stem Cells, Xuzhou 221002, China
| |
Collapse
|
5
|
Wang XM, Zhou Y, Zhang JL, Zhou HY, Zhang Q, Sun Q, Li HJ, Xu LY, Yao SN, Yao ZH, Yan DM, Xu KL, Sang W. [Allogeneic hematopoietic stem cell transplantation combined with CD7 CAR-T for the treatment of T lymphoblastic lymphoma: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:864-865. [PMID: 38049342 PMCID: PMC10694072 DOI: 10.3760/cma.j.issn.0253-2727.2023.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Indexed: 12/06/2023]
Affiliation(s)
- X M Wang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - Y Zhou
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - J L Zhang
- Department of Rehabilitation, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China
| | - H Y Zhou
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - Q Zhang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - Q Sun
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - H J Li
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - L Y Xu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - S N Yao
- Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China
| | - Z H Yao
- Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China
| | - D M Yan
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - K L Xu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | - W Sang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| |
Collapse
|
6
|
Shen ZY, Chen XC, Shan HR, Jia T, Gu WY, Wang F, Teng QL, Wang L, Wang CL, Shi YY, Zhang H, Miao YQ, Zhu TG, Ji CY, Ye JJ, Zhang MZ, Zhang XD, Wang L, Xu KL, Sang W. [Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase: a multicenter retrospective study]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:642-648. [PMID: 37803837 PMCID: PMC10520233 DOI: 10.3760/cma.j.issn.0253-2727.2023.08.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Indexed: 10/08/2023]
Abstract
Objective: To explore the prognostic factors of extracellular NK/T cell lymphoma (ENKTL) treated with pegaspargase/L-asparaginase. Methods: The clinical data of 656 ENKTL patients diagnosed at 11 medical centers in the Huaihai Lymphoma Working Group from March 2014 to April 2021 were retrospectively analyzed. The patients were randomly divided into two groups: a training set (460 cases) and a validation set (196 cases) at 7∶3, and the prognostic factors of the patients were analyzed. A prognostic scoring system was established, and the predictive performance of different models was compared. Results: Patients' median age was 46 (34, 57) years, with 456 males (69.5% ) and 561 nasal involvement (85.5% ). 203 patients (30.9% ) received a chemotherapy regimen based on L-asparaginase combined with anthracyclines, and the 5-year overall survival rate of patients treated with P-GEMOX regimen (pegaspargase+gemcitabine+oxaliplatin) was better than those treated with SMILE regimen (methotrexate+dexamethasone+cyclophosphamide+L-asparaginase+etoposide) (85.9% vs 63.8% ; P=0.004). The results of multivariate analysis showed that gender, CA stage, the Eastern Cooperative Oncology Group performance status (ECOG PS) score, HGB, and EB virus DNA were independent influencing factors for the prognosis of ENKTL patients (P<0.05). In this study, the predictive performance of the prognostic factors is superior to the international prognostic index, Korean prognostic index, and prognostic index of natural killer lymphoma. Conclusion: Gender, CA stage, ECOG PS score, HGB, and EB virus DNA are prognostic factors for ENKTL patients treated with pegaspargase/L-asparaginase.
Collapse
Affiliation(s)
- Z Y Shen
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, China
| | - X C Chen
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - H R Shan
- Department of Hematology, Shuyang Hospital of Traditional Chinese Medicine, Suqian 223600, China
| | - T Jia
- Department of Hematology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - W Y Gu
- Department of Hematology, the First People's Hospital of Changzhou, Changzhou 213003, China
| | - F Wang
- Department of Hematology, the First People's Hospital of Changzhou, Changzhou 213003, China
| | - Q L Teng
- Department of Hematology, Taian Central Hospital, Taian 271000, China
| | - L Wang
- Department of Hematology, Taian Central Hospital, Taian 271000, China
| | - C L Wang
- Department of Hematology, Huai'an First People's Hospital, Huaian 223000, China
| | - Y Y Shi
- Department of Hematology, Huai'an First People's Hospital, Huaian 223000, China
| | - H Zhang
- Department of Hematology, the Affiliated Hospital of Jining Medical University, Jining 272000, China
| | - Y Q Miao
- Department of Hematology, Yancheng First People's Hospital, Yancheng 224001, China
| | - T G Zhu
- Department of Hematology, the General Hospital of Wanbei Coal-Electric Group, Suzhou 234000, China
| | - C Y Ji
- Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China
| | - J J Ye
- Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China
| | - M Z Zhang
- Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - X D Zhang
- Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - L Wang
- Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - K L Xu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - W Sang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| |
Collapse
|
7
|
Liu Y, Ding S, Sun JF, Li PP, Li XQ, Zeng LY, Xu KL, Qiao JL. [The effect of platelet infusion on the repair of bone marrow hematopoietic niche damage in mice induced by (60)Co radiation and hematopoietic reconstruction after bone marrow transplantation]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:635-641. [PMID: 37803836 PMCID: PMC10520226 DOI: 10.3760/cma.j.issn.0253-2727.2023.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Indexed: 10/08/2023]
Abstract
Objective: To observe the effect of platelets on hematopoietic stem cell (HSCs) implantation in mice with radiation-induced bone marrow injury and bone marrow transplantation models. Methods: ①Male C57BL/6 mice were divided into a single irradiation group and a radiation infusion group after receiving (60)Co semimyeloablative irradiation for 18-10 weeks. The irradiation infusion group received 1×10(8) platelets expressing GFP fluorescent protein. ② The allogeneic bone marrow transplantation model was established. The experimental groups included the simple transplantation group (BMT) and the transplantation infusion group (BMT+PLT). The BMT group was infused through the tail vein only 5 × 10(6) bone marrow cells, the BMT+PLT group needs to be infused with bone marrow cells at the same time 1× 10(8) platelets. ③ Test indicators included peripheral blood cell and bone marrow cell counts, flow cytometry to detect the proportion of hematopoietic stem cell (HSC) and hematopoietic progenitor cells, bone marrow cell proliferation and apoptosis, and pathological observation of vascular niche damage and repair. Results: ①On the 3rd, 7th, 14(th), and 21st days after irradiation, the bone marrow cell count of the infusion group was higher than that in the single irradiation group (P<0.05), and the peripheral blood cell count was also higher. A statistically significant difference was found between the white blood cell count on the 21st day and the platelet count on the 7th day (P<0.05). In the observation cycle, the percentage of bone marrow cell proliferation in the infusion group was higher, while the percentage of apoptosis was lower. ② The results of bone tissue immunofluorescence after irradiation showed that the continuity of hematopoietic niche with red fluorescence was better in the irradiation infusion group. ③The chimerism percentage in the BMT+PLT group was always higher than that in the BMT group after transplantation.④ The BMT+PLT group had higher bone marrow cell count and percentage of bone marrow cell proliferation on the 7th and 28th day after transplantation than that in the BMT group, and the percentage of bone marrow cell apoptosis on the 14th day was lower than that in the BMT group (P<0.05). After the 14th day, the percentage of stem progenitor cells in the bone marrow cells of mice was higher than that in the BMT group (P<0.05). ⑤The immunohistochemical results of bone marrow tissue showed that the continuity of vascular endothelium in the BMT+PLT group was better than that in the BMT group. Conclusion: Platelet transfusion can alleviate the injury of vascular niche, promotes HSC homing, and is beneficial to hematopoietic reconstruction.
Collapse
Affiliation(s)
- Y Liu
- Department of Clinical Laboratory, the Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China
| | - S Ding
- Department of Clinical Laboratory, the Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China
| | - J F Sun
- Department of Clinical Laboratory, the Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China
| | - P P Li
- Department of Clinical Laboratory, the Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China
| | - X Q Li
- Blood Disease Institute, Xuzhou Medical University, Key Laboratory of Bone Marrow Stem Cell, Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China
| | - L Y Zeng
- Blood Disease Institute, Xuzhou Medical University, Key Laboratory of Bone Marrow Stem Cell, Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China
| | - K L Xu
- Blood Disease Institute, Xuzhou Medical University, Key Laboratory of Bone Marrow Stem Cell, Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China
| | - J L Qiao
- Blood Disease Institute, Xuzhou Medical University, Key Laboratory of Bone Marrow Stem Cell, Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China
| |
Collapse
|
8
|
Wang SY, Zhao LN, Cheng H, Shi M, Chen W, Qi KM, Sun C, Wang X, Cao J, Xu KL. [Long-term safety and activity of humanized CD19 chimeric antigen receptor T cells for children and young adults with relapsed/refractory acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi 2022; 43:557-561. [PMID: 36709132 PMCID: PMC9395560 DOI: 10.3760/cma.j.issn.0253-2727.2022.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Download PDF] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Indexed: 11/17/2022]
Abstract
Objective: To investigate the efficacy and safety of humanized CD19-specific chimeric antigen receptor T cells (hCART19s) in treating children and young adults with relapsed/refractory acute lymphoblastic leukemia (R/R ALL) and to analyze relevant factors affecting its curative effect and prognosis. Methods: We conducted a single-center clinical trial involving 31 children and young adult patients with R/R B-ALL who were treated with humanized CD19-specific CAR-T cells (hCART19s) from May 2016 to September 2021. Results: Results showed that 27 (87.1%) patients achieved complete remission (CR) or CR with incomplete count recovery (CRi) one month after CAR-T cell infusion. During treatment, 20 (64.5%) patients developed grade 1-2 cytokine release syndrome (CRS) , and 4 (12.9%) developed grade 3 CRS. Additionally, two patients had grade 1 neurological events. During the follow-up with a median time of 19.3 months, the median event-free survival (EFS) was 15.7 months (95% CI 8.7-22.5) , and the median overall survival (OS) was 32.2 months (95% CI 10.6-53.9) . EFS and OS rates were higher in patients who have undergone hemopoietic stem cell transplantation (HSCT) than in those without [EFS: (75.0 ± 12.5) % vs (21.1 ± 9.4) %, P=0.012; OS: (75.0 ± 12.5) % vs (24.6 ± 10.2) %, P=0.035]. The EFS and OS rates were significantly lower in patients with >3 treatment lines than in those with <3 treatment lines [EFS: 0 vs (49.5±10.4) %, P<0.001; OS: 0 vs (52.0±10.8) %, P<0.001]. To the cutoff date, 12 patients presented with CD19(+) relapse, and 1 had CD19(-) relapse. Conclusion: hCART19s are effective in treating pediatric and young adult R/R ALL patients, with a low incidence of severe adverse events and reversible symptoms. Following HSCT, the number of treatment lines can affect the long-term efficacy and prognosis of pediatric and young adult R/R ALL patients.
Collapse
Affiliation(s)
- S Y Wang
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - L N Zhao
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - H Cheng
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - M Shi
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - W Chen
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - K M Qi
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - C Sun
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - X Wang
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - J Cao
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - K L Xu
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| |
Collapse
|
9
|
Ge J, Zhao TT, Wan CY, Xia JY, Guo SY, Yu MX, Chen J, Wang Y, Xu KL, Li ZY. [Comparison of single infusion of anti-BCMA versus combined infusion of anti-CD19 chimeric antigen receptor T cells for immune reconstruction in relapsed/refractory multiple myeloma]. Zhonghua Xue Ye Xue Za Zhi 2021; 42:733-738. [PMID: 34753227 PMCID: PMC8607032 DOI: 10.3760/cma.j.issn.0253-2727.2021.09.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: We observed and compared the differences in immune reconstruction between single-infusion anti-B-cell maturation antigen (BCMA) , chimeric antigen receptor T cells (CAR-T) , and combined infusion of anti-CD19 CAR-T cells in the treatment of recurrent/refractory multiple myeloma (RRMM) . Methods: Sixty-one patients with RRMM who underwent CAR-T cell therapy in our hospital from June 2017 to December 2020 were selected. Among them, 26 patients received anti-BCMA target, and 35 patients received anti-BCMA combined with anti-CD19 target. Using flow cytometry, we determined T cell subsets (CD3(+), CD4(+), CD8(+), CD4(+)/CD8(+)) , B cells (CD19(+)) , and NK cells (CD16(+) CD56(+)) at different time points before and after CAR-T treatment, and detected immunoglobulin IgG, IgA and IgM levels by immunoturbidimetry. We compared the reconstruction rules of lymphocyte subsets and immunoglobulins in the two groups. Results: CD8(+) T lymphocytes recovered most rapidly after the infusion of CAR-T cells, returning to pre-infusion levels at 3 months and 1 month after infusion, respectively[BCMA: 695 (357, 1264) /μl vs 424 (280, 646) /μl; BCMA+CD19: 546 (279, 1672) /μl vs 314 (214, 466) /μl]. NK cells returned to normal levels at 3 months after infusion in both groups[BCMA: 171 (120, 244) /μl, BCMA+CD19: 153 (101, 218) /μl (Normal reference range 150-1100/μl) ]; however, the NK cells were not maintained at stable levels in the BCMA CAR-T cells group. The recovery of CD4(+) T lymphocytes in both groups was slow and remained persistently low within 12 months after infusion, and no recovery was observed in most patients. The reversal of the ratio of CD4(+)/CD8(+) lasted for more than a year. The levels of CD19(+) B cells in both groups returned to baseline 3 months after infusion[BCMA: 62 (10, 72) /μl vs 57 (24, 78) /μl; BCMA+CD19: 40 (4, 94) /μl vs 29 (14, 46) /μl]. IgG returned to the pre-infusion level 12 months after infusion in the group with anti-BCMA cells alone, but not in the group with combined infusion of CD19 CAR T cells[7.82 (6.03, 9.64) g/L vs 6.92 (4.62, 12.76) g/L]. IgA returned to pre-infusion levels at 9 and 12 months after infusion, respectively[BCMA: 0.46 (0.07, 0.51) g/L vs 0.22 (0.12, 4.01) g/L; BCMA+CD19: 0.46 (0.22, 0.98) g/L vs 0.27 (0.10, 0.53) g/L]. IgM in both groups returned to pre-infusion levels 6 months after infusion[BCMA: 0.43 (0.06, 0.60) g/L vs 0.20 (0.13, 0.37) g/L; BCMA+CD19: 0.53 (0.10, 0.80) g/L vs 0.16 (0.11, 0.28) g/L]. There was no significant difference in the indexes of lymphocyte subpopulation reconstruction and immunoglobulin recovery between the two groups at each time point. Conclusion: This study showed that in patients with RRMM treated with CAR-T cells, the appropriate target antigen can be selected without considering the difference of immune reconstruction between anti-BCMA CAR-T and combined anti-CD19 CAR-T therapy.
Collapse
Affiliation(s)
- J Ge
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - T T Zhao
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - C Y Wan
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - J Y Xia
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - S Y Guo
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - M X Yu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - J Chen
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - Y Wang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - K L Xu
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - Z Y Li
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| |
Collapse
|
10
|
Zhang L, Wang Y, Xu KL. [Mechanisms and prevention strategies of relapse and resistance after BCMA-CAR-T cell in multiple myeloma]. Zhonghua Xue Ye Xue Za Zhi 2021; 42:778-781. [PMID: 34753237 PMCID: PMC8607042 DOI: 10.3760/cma.j.issn.0253-2727.2021.09.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- L Zhang
- Blood Diseases Institute, Xuzhou Medical University; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University; Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221002, China
| | - Y Wang
- Blood Diseases Institute, Xuzhou Medical University; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University; Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221002, China
| | - K L Xu
- Blood Diseases Institute, Xuzhou Medical University; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University; Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221002, China
| |
Collapse
|
11
|
Hu CY, Xu KL, Pan B. [Research progress of drug combination in overcoming drug resistance of CAR-T cell therapy]. Zhonghua Nei Ke Za Zhi 2021; 60:681-685. [PMID: 34619850 DOI: 10.3760/cma.j.cn112138-20200731-00723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- C Y Hu
- Department of Hematology,Affiliated Hospital of Xuzhou Medical University;Blood Diseases Institute,Xuzhou Medical University, Xuzhou 221002, China
| | - K L Xu
- Department of Hematology,Affiliated Hospital of Xuzhou Medical University;Blood Diseases Institute,Xuzhou Medical University, Xuzhou 221002, China
| | - B Pan
- Department of Hematology,Affiliated Hospital of Xuzhou Medical University;Blood Diseases Institute,Xuzhou Medical University, Xuzhou 221002, China
| |
Collapse
|
12
|
Huo L, Xu KL, Wang H. Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic. World J Clin Cases 2021; 9:1058-1078. [PMID: 33644169 PMCID: PMC7896657 DOI: 10.12998/wjcc.v9.i5.1058] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 12/01/2020] [Accepted: 12/23/2020] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic, numerous studies have been published on SARS-CoV-2-related encephalitis/meningitis, but it has not been established if there are specific clinical characteristics of encephalitis/meningitis associated with SARS-CoV-2 infection.
AIM To identify the specific clinical features of cases of encephalitis/meningitis associated with SARS-CoV-2 infection in the context of this virus infection pandemic and investigate their relationship with SARS-CoV-2 infection.
METHODS We searched PubMed, and included single case reports and case series with full text in English, reporting original data of coronavirus disease-19 (COVID-19) patients with encephalitis/meningitis and a confirmed recent SARS-CoV-2 infection. Clinical data were extracted.
RESULTS We identified 22 articles (18 single case reports and 4 case series) reporting on a total of 32 encephalitis/meningitis patients with confirmed SARS-CoV-2 infection. SARS-CoV-2 infection was confirmed through reverse transcriptase-polymerase-chain-reaction (RT-PCR) in 96.88% of cases. A total of 22 (68.75%) patients had symptoms of SARS-CoV-2 infection in about 1 wk (7.91 d) preceding the onset of neurologic symptoms. The most common neurological symptoms were consciousness disturbance (59.38%), seizure (21.88%), delirium (18.75%), and headache (18.75%). Four cases were confirmed by positive RT-PCR results in cerebrospinal fluid (CSF), one was confirmed by positive RT-PCR results in postoperative brain tissue, and one by the presence of SARS-CoV-2 antibodies in CSF. The mainly damaged targets identified by neuroimaging included the temporal lobe (15.63%), white matter (12.5%), frontal lobe (9.38%), corpus callosum (9.38%), and cervical spinal cord (9.38%). Eighty percent of patients had electroencephalograms that showed a diffuse slow wave. Twenty-eight (87.5%) patients were administered with specific treatment. The majority (65.63%) of patients improved following systemic therapy.
CONCLUSION Encephalitis/meningitis is the common neurological complication in patients with COVID-19. The appropriate use of definitions and exclusion of potential similar diseases are important to reduce over-diagnosis of SARS-CoV-2 associated encephalitis or meningitis.
Collapse
Affiliation(s)
- Liang Huo
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China
| | - Kai-Li Xu
- Department of Pediatric Neurology, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, Henan Province, China
- Department of Pediatric Neurology, Henan Children’s Hospital, Zhengzhou 450018, Henan Province, China
| | - Hua Wang
- Department of Pediatric Neurology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China
| |
Collapse
|
13
|
Wang SY, Cao J, Xu KL. [Mechanisms and countermeasures in relapse of relapsed/refractory non-Hodgkin lymphoma after treatment of CD19 chimeric antigen receptor T cells]. Zhonghua Xue Ye Xue Za Zhi 2020; 41:437-440. [PMID: 32536147 PMCID: PMC7342074 DOI: 10.3760/cma.j.issn.0253-2727.2020.05.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- S Y Wang
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - J Cao
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | - K L Xu
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| |
Collapse
|
14
|
Cheng H, Wang X, Xu KL. [Eltrombopag combined with cyclosporine alone for treatment of very severe aplastic anemia: a case report]. Zhonghua Xue Ye Xue Za Zhi 2020; 40:612. [PMID: 32397030 PMCID: PMC7364895 DOI: 10.3760/cma.j.issn.0253-2727.2019.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- H Cheng
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221000, China
| | | | | |
Collapse
|
15
|
Yang JJ, Sang W, Xu KL. [Research progress of CAR-T cell therapy for relapsed/refractory diffuse large B-cell lymphoma]. Zhonghua Nei Ke Za Zhi 2019; 58:849-852. [PMID: 31665867 DOI: 10.3760/cma.j.issn.0578-1426.2019.11.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- J J Yang
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | | | | |
Collapse
|
16
|
Yan ZL, Li ZY, Xu KL. [Chimeric antigen receptor T cells for hematological malignancies: current understanding and future challenge]. Zhonghua Nei Ke Za Zhi 2019; 58:793-795. [PMID: 31665852 DOI: 10.3760/cma.j.issn.0578-1426.2019.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Z L Yan
- Blood Diseases Institute, Xuzhou Medical University, Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | | | | |
Collapse
|
17
|
Zhou C, Li HF, Yin YX, Shi ZZ, Li T, Feng XY, Zhang JW, Song CX, Cui XS, Xu KL, Zhao YW, Hou WB, Lu ST, Liu G, Li MQ, Ma JY, Toft E, Volinsky AA, Wan M, Yao XJ, Wang CB, Yao K, Xu SK, Lu H, Chang SF, Ge JB, Wang LN, Zhang HJ. Long-term in vivo study of biodegradable Zn-Cu stent: A 2-year implantation evaluation in porcine coronary artery. Acta Biomater 2019; 97:657-670. [PMID: 31401346 DOI: 10.1016/j.actbio.2019.08.012] [Citation(s) in RCA: 53] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Revised: 07/11/2019] [Accepted: 08/06/2019] [Indexed: 01/11/2023]
Abstract
In the present study, a novel biodegradable Zn-0.8Cu coronary artery stent was fabricated and implanted into porcine coronary arteries for up to 24 months. Micro-CT analysis showed that the implanted stent was able to maintain structural integrity after 6 months, while its disintegration occurred after 9 months of implantation. After 24 months of implantation, approximately 28 ± 13 vol% of the stent remained. Optical coherence tomography and histological analysis showed that the endothelialization process could be completed within the first month after implantation, and no inflammation responses or thrombosis formation was observed within 24 months. Cross-section analysis indicated that the subsequent degradation products had been removed in the abluminal direction, guaranteeing that the strut could be replaced by normal tissue without the risk of contaminating the circulatory system, causing neither thrombosis nor inflammation response. The present work demonstrates that the Zn-0.8Cu stent has provided sufficient structural supporting and exhibited an appropriate degradation rate during 24 months of implantation without degradation product accumulation, thrombosis, or inflammation response. The results indicate that the Zn-0.8Cu coronary artery stent is promising for further clinical applications. STATEMENT OF SIGNIFICANCE: Although Zn and its alloys have been considered to be potential candidates of biodegradable metals for vascular stent use, by far, no Zn-based stent with appropriate medical device performance has been reported because of the low mechanical properties of zinc. The present work presents promising results of a Zn-Cu biodegradable vascular stent in porcine coronary arteries. The Zn-Cu stent fabricated in this work demonstrated adequate medical device performance both in vitro and in vivo and degraded at a proper rate without safety problems induced. Furthermore, large animal models have more cardiovascular similarities as humans. Results of this study may provide further information of the Zn-based stents for translational medicine research.
Collapse
Affiliation(s)
- Chao Zhou
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China; Department of Interventional and Vascular Surgery, The Tenth People's Hospital of Shanghai, Tongji University, Shanghai 200072, PR China; National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Hua-Fang Li
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China
| | - Yu-Xia Yin
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China; National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Zhang-Zhi Shi
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China
| | - Ting Li
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China
| | - Xiang-Yi Feng
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Jun-Wei Zhang
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Cai-Xia Song
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Xiao-Shan Cui
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Kai-Li Xu
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Yan-Wei Zhao
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Wen-Bo Hou
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Shou-Tao Lu
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Guang Liu
- National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China
| | - Mao-Quan Li
- Department of Interventional and Vascular Surgery, The Tenth People's Hospital of Shanghai, Tongji University, Shanghai 200072, PR China
| | - Jian-Ying Ma
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032 PR China
| | - Egon Toft
- Biomedical Research Center, College of Medicine, Qatar University, Shareh Jamiaa, Post Box 2716, Doha, Qatar
| | - Alex A Volinsky
- Department of Mechanical Engineering, University of South Florida, Tampa, FL 33620, USA
| | - Min Wan
- Shandong Quality Inspection Center for Medical Devices, No. 15166 Century Avenue, Jinan H-T Industrial Development Zone, Shandong 250101, PR China
| | - Xiu-Jun Yao
- Shandong Quality Inspection Center for Medical Devices, No. 15166 Century Avenue, Jinan H-T Industrial Development Zone, Shandong 250101, PR China
| | - Chang-Bin Wang
- Shandong Quality Inspection Center for Medical Devices, No. 15166 Century Avenue, Jinan H-T Industrial Development Zone, Shandong 250101, PR China
| | - Kang Yao
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032 PR China
| | - Shi-Kun Xu
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032 PR China
| | - Hao Lu
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032 PR China
| | - Shu-Fu Chang
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032 PR China
| | - Jun-Bo Ge
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032 PR China.
| | - Lu-Ning Wang
- Beijing Advanced Innovation Center for Materials Genome Engineering, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China.
| | - Hai-Jun Zhang
- Department of Interventional and Vascular Surgery, The Tenth People's Hospital of Shanghai, Tongji University, Shanghai 200072, PR China; National United Engineering Laboratory for Biomedical Material Modification, Branden Industrial Park, Qihe Economic & Development Zone, Dezhou City, Shandong 251100, PR China; Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Niels Jernes Vej 10, Aalborg Ø 9220, Denmark.
| |
Collapse
|
18
|
Xu KL, Yang H, Xie JX, Wang JF, Shen WM, Ling C, Fu XJ, Xia YY, Han CY, Zhong LS, Fan YY. [Study on purification effect of formaldehyde in cleanroom by new return air device]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 37:347-351. [PMID: 31177712 DOI: 10.3760/cma.j.issn.1001-9391.2019.05.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To effectively reduce the concentration of poisons in cleanroom, protect the health of workers, realize the optimization and automatic control of the new return air device. And the influence of initial concentration, air volume, temperature and relative humidity of formaldehyde on the purification effect of the new return air device was explored. Methods: The purification effect of the new return air device installed with the activated carbon and the photocatalyst purification net or ordinary activated carbon purification network was tested in a 60 m(3) simulated cleanroom. The concentration of formaldehyde was determined by solution absorption-phenol reagent spectrophotometry. Based on the single factor experiment to determine the combination of two purification nets. The effects of air volume, initial formaldehyde concentration, temperature and relative humidity on the purification effect of the new return air device were investigated by orthogonal test. Then, the performance parameters of the return air device to purify formaldehyde were determined. Results: The formaldehyde purification efficiency of the two types of purification nets in the new return air device was higher than that of the ordinary activated carbon purification network (P<0.05) . The combination of activated carbon and photocatalyst purification net has no effect on the formaldehyde purification efficiency of the return air device (P>0.05) . According to the direct analysis and variance analysis, air volume was the most sensitive factor (F value is 18.894, P<0.05) , followed by initial concentration (F value is 16.128, P<0.05) , while temperature and relative humidity have little effect (F value is 0.041 and 0.599, respectively, P>0.05) . LSD analysis showed that there was no significant difference in the purification efficiency of formaldehyde between 475 m(3)/h and 626 m(3)/h (P>0.05) . From the perspective of formaldehyde purification efficiency and energy saving, when the air volume is set to 475 m(3)/h, the new return air device has higher purification efficiency for high concentration of formaldehyde. Conclusion: The new return air device consisting of activated carbon and photocatalyst purification net can play a good purification role in cleanroom with different temperatures and different humidity. Its formaldehyde purification efficiency is affected by air volume and initial concentration.
Collapse
Affiliation(s)
- K L Xu
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China; Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210028, China
| | - H Yang
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
| | - J X Xie
- Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210028, China
| | - J F Wang
- Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210028, China
| | - W M Shen
- Suzhou Goldswallow Purification Equipment Co., Ltd, Suzhou 215000, China
| | - C Ling
- Suzhou Goldswallow Purification Equipment Co., Ltd, Suzhou 215000, China
| | - X J Fu
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
| | - Y Y Xia
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
| | - C Y Han
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
| | - L S Zhong
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
| | - Y Y Fan
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
| |
Collapse
|
19
|
Zhang CX, Cheng H, Han X, Qi KM, Chen W, Wu QY, Cao J, Xu KL. [Construction and in vitro verification of a new humanized anti-CD19 CAR-T cells with high affinity]. Zhonghua Xue Ye Xue Za Zhi 2019; 39:465-470. [PMID: 30032561 PMCID: PMC7342930 DOI: 10.3760/cma.j.issn.0253-2727.2018.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
目的 构建人源化抗CD19嵌合抗原受体T细胞(CAR-T),通过体外实验验证其杀伤白血病细胞的能力。 方法 将人CD19的鼠源抗体(FMC63)进行了人源化改造,获得高亲和力的人源化CD19抗体;构建携带人源化CD19 CAR慢病毒载体,感染T细胞获得人源化CD19 CAR-T细胞(hCART19);按不同效靶比将效应细胞[hCART19、未转染的T细胞(阴性组)及对照病毒转染的T细胞(对照组)]及靶细胞(CHO-K1-CD19及Raji细胞)混合培养,LDH释放实验及ELISA法检测hCART19杀伤白血病细胞的能力及细胞因子释放水平;白血病小鼠模型检测hCART19的杀瘤效果。 结果 LDH释放实验证实随着效靶比的不断增加,对靶细胞的杀伤率逐渐增加,当效靶比为10∶1时hCART19组的杀伤率最大,在Raji细胞中为(87.56±1.99)%,明显高于阴性组[(19.31±1.16)%]及对照组[(21.35±1.19)%](P值均<0.001)。ELISA法检测显示Raji细胞作为靶细胞时,hCART19组IL-2水平[(10.56±0.88)pg/ml]及IFN-γ[(199.02±12.66)pg/ml]较阴性组[IL-2:(3.55±0.26)pg/ml;IFN-γ:(37.63±0.85)pg/ml]及对照组[IL-2:(2.92±0.32)pg/ml;IFN-γ:(52.07±3.33)pg/ml]明显升高(P值均<0.001)。以上实验在CHO-K1-CD19细胞作为靶细胞时也出现了相似的结果。给予白血病小鼠模型尾静脉分别注射hCART19、对照病毒转染的T细胞及未转染的T细胞,结果显示hCART19组小鼠存活时间>40 d,另外两组小鼠在20~30 d全部死亡,差异有统计学意义(χ2=11.73,P=0.008)。 结论 成功构建了具有抗白血病活性的人源化CD19 CAR-T细胞,为下一步的临床研究奠定了基础。
Collapse
Affiliation(s)
- C X Zhang
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Sun AN, Tian XP, Cao XS, Ouyang J, Gu J, Xu KL, Yu K, Zeng QS, Sun ZM, Chen GA, Gao SJ, Zhou J, Wang JH, Yang LH, Luo JM, Zhang M, Guo XH, Wang XM, Zhang X, Shi KQ, Sun H, Ding XM, Hu JD, Zheng RJ, Zhao HG, Hou M, Wang X, Chen FP, Zhu Y, Liu H, Huang DP, Liao AJ, Ma LM, Su LP, Liu L, Zhou ZP, Huang XB, Sun XM, Wu DP. [Efficacy and safety of IA regimen containing different doses of idarubicin in de-novo acute myeloid leukemia for adult patients]. Zhonghua Xue Ye Xue Za Zhi 2019; 38:1017-1023. [PMID: 29365393 PMCID: PMC7342198 DOI: 10.3760/cma.j.issn.0253-2727.2017.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
目的 探讨含不同剂量去甲氧柔红霉素(IDA 8、10、12 mg/m2)的IA方案诱导治疗成人初发急性髓系白血病(AML)(非急性早幼粒细胞白血病)的临床疗效和安全性。 方法 采用多中心、单盲、非随机、临床对照研究,纳入2011年5月至2015年3月苏州大学附属第一医院及其他36家单位收治的1 215例成人初发AML患者,根据诱导化疗方案中IDA的剂量对患者进行分组,分析不同剂量IDA联合阿糖胞苷(100 mg/m2)组成的IA方案在成人初发AML诱导治疗中的完全缓解(CR)率、血液学及非血液学不良事件。 结果 可纳入缓解率分析的AML患者共1 207例,IDA 8 mg/m2、10 mg/m2和12 mg/m2组的CR率分别为73.6%(215/292)、84.1%(662/787)和86.7%(111/128),差异有统计学意义(P<0.001);以IDA 8 mg/m2组为参照组,在调整了年龄、骨髓原始细胞比例、FAB分型、危险度分层后,IDA 10 mg/m2和IDA 12 mg/m2为影响患者CR的有利因素[OR=0.49(95% CI 0.34~0.70),P<0.001;OR=0.36(95%CI 0.18~0.71),P=0.003]。在中、低危组中三组CR率分别为76.5%(163/213)、86.9%(506/582)和86.1%(68/79),差异有统计学意义(P=0.007);在调整了年龄、骨髓原始细胞比例、FAB分型因素后,IDA 10 mg/m2为影响患者CR的有利因素[OR=0.47(95% CI 0.31~0.71),P<0.001]。在高危组中,三组CR率分别为50.0%(18/36)、60.6%(43/71)和81.8%(18/22),差异无统计学意义(P=0.089),但在调整了年龄、骨髓原始细胞比例、FAB分型因素后,IDA 12 mg/m2为影响患者CR的有利因素[OR=0.22(95% CI 0.06~0.80),P=0.022]。8 mg/m2、10 mg/m2和12 mg/m2组中性粒细胞≤0.5×109/L的中位持续时间分别为14(11~18)、15(11~20)和18(14~22)d,差异有统计学意义(P=0.012);三组PLT≤20×109/L的中位持续时间分别为14(7~17)、15(11~20)和17(15~21)d,差异有统计学意义(P=0.001);三组肺部感染发生率分别为9.8%、13.5%和25.2%,差异有统计学意义(P<0.001)。 结论 在中国成人(18~60岁)初发AML中,建议中、低危组患者采用含IDA 10 mg/m2的IA方案进行诱导治疗;而高危组AML建议选择含IDA 12 mg/m2的IA方案进行诱导治疗。
Collapse
Affiliation(s)
- A N Sun
- Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou Institute of Blood and Marrow Transplantation, Suzhou 215006, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - D P Wu
- Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou Institute of Blood and Marrow Transplantation, Suzhou 215006, China
| |
Collapse
|
21
|
Mo HM, Wu QY, Han DY, Liu R, Ma X, Zhou P, Xu KL. [Effects of PSMB5 on proliferation and bortezomib chemo-resistance in human myeloma cells and its related molecular mechanisms]. Zhonghua Xue Ye Xue Za Zhi 2019; 38:1053-1057. [PMID: 29365400 PMCID: PMC7342182 DOI: 10.3760/cma.j.issn.0253-2727.2017.12.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Objective: To investigate the effects of proteasome beta 5 subunit (PSMB5) on proliferation and bortezomib (BTZ) chemo-sensitivity of multiple myeloma (MM) and its related molecular mechanisms. Methods: We used two MM cell lines, RPMI 8226 and BTZ drug-resistant cell line RPMI 8226/BTZ100 (hereinafter referred to as BTZ100) , as the research object. PSMB5 was overexpressed or knocked down in two myeloma cell lines via lentivirus transfection. CCK8 assay was used to detect the impact of PSMB5 on cell viability and bortezomib sensitivity in human myeloma cells; Using flow cytometry to test the effects of PSMB5 on apoptosis rate of human myeloma cells under the treatment of bortezomib; Apoptosis-related gene expression of Bax, Bcl-2, p-Akt and cleaved caspase-3 were detected by Western blot. Results: ①PSMB5 overexpression and knockdown were successfully constructed in RPMI 8226 and BTZ100 cells. ②PSMB5 expression was positively correlated with cell proliferation of RPMI 8226 and BTZ100 cells (P<0.05) . ③The cell viability was lower after PSMB5 knockdown in RPMI 8226 cells than control cells under the same concentration of BTZ[IC(50) at 24 h: (7.01±0.47) and (9.64±0.55) nmol/L respectively, t=6.289, P=0.003]. The cell viability was higher after PSMB5 overexpression in RPMI 8226 cells than control cells under the same concentration of BTZ[IC(50) at 24 h: (10.99±0.58) and (9.51±0.37) nmol/L respectively, t=3.724, P=0.020) . PSMB5 expression was negatively correlated with the sensitivity of RPMI 8226 cells to BTZ. The results of BTZ100 cells were similar. ④The expression of PSMB5 was negatively correlated with the apoptosis of RPMI 8226 and BTZ100 under the treatment of BTZ. ⑤Meanwhile, PSMB5 knockdown could increase the expression of pro-apoptosis gene Bax and cleaved caspase-3 and decrease the expression of anti-apoptotic gene Bcl-2 and p-Akt. PSMB5 over-expression has the opposite results. Conclusion: PSMB5 knockdown could improve the bortezomib sensitivity of MM cells via activation of apoptosis signaling. PSMB5 may be a potential therapeutic target for MM.
Collapse
Affiliation(s)
- H M Mo
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | | | | | | | | | | | | |
Collapse
|
22
|
Xia F, Wu YJ, Lu ZZ, Xu KL, Pan B. [The role of IL-22 in T cell reconstitution after thymus damage induced by ionizing radiation]. Zhonghua Xue Ye Xue Za Zhi 2018; 39:761-765. [PMID: 30369189 PMCID: PMC7342262 DOI: 10.3760/cma.j.issn.0253-2727.2018.09.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Indexed: 12/15/2022]
Abstract
Objective: To explore the levels of IL-22 in thymus damaged by γ-ray total body irradiation (TBI), and to study the role of IL-22 in T cell reconstitution after thymic injury induced by TBI. Methods: To induce thymic injury, mice were treated by sub-lethal TBI. Levels of intra-thymic and circulatory IL-22 were detected by using ELISA assay. Untreated mice were used as control. After receiving sub-lethal TBI, mice were intraperitoneally injected with PBS or recombinant mouse IL-22, which were marked as TBI+PBS or TBI+IL-22, respectively. Mice were monitored for counts of total thymic cells and circulatory white blood cells. Flow cytometry was applied to analyze percentages of thymic epithelial cells (TEC), thymocyte subsets and circulatory T cells. Real-time PCR assay was applied to analyze the mRNA expression levels of Foxn1, Ccl25, Aire and Dll4 in thymus. Results: ①Sub-lethal TBI treated mice expressed higher levels of intra-thymic and circulatory IL-22, compared with untreated ones (all P<0.05). ②After injection of recombinant IL-22, TBI+IL-22 mice had higher levels of intra-thymic IL-22 than TBI+PBS mice (all P<0.05). ③On day 14 after irradiation, real-time PCR assay showed that TBI+IL-22 mice had higher mRNA levels of Foxn1, Ccl25, Aire and Dll4 in thymus compared with TBI+PBS ones. Meanwhile, the TBI+IL-22 mice had higher counts of total thymic cells[(5.93±3.19)×10(6)/ml vs (1.42±0.46)×10(6)/ml, t=3.128, P=0.033] and circulatory white blood cells[(3.08±0.94)×10(6)/ml vs (1.43±0.30)×10(6)/ml, t=3.730, P=0.015] than those of TBI+PBS mice. Flow cytometry analysis indicated that TBI+IL-22 mice had higher counts of TEC and thymocytes than TBI+PBS mice on day 14 after irradiation (all P<0.05). On days 7 and 14 after irradiation, TBI+IL-22 mice had higher counts of circulatory white blood cells and T cells than TBI+PBS mice (all P<0.05). Conclusion: Sub-lethal TBI induces upregulation of intra-thymic IL-22, and injecting of recombinant IL-22 increases level of IL-22 in thymus. Injecting of recombinant IL-22 improves recovery of TEC and increases numbers of thymocyte subsets and circulatory T cell after thymic injury.
Collapse
Affiliation(s)
- F Xia
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
| | | | | | | | | |
Collapse
|
23
|
Yan XJ, Fang S, Huang GW, Wang J, Xu KL, Zhang XX. [Clinical study of nasopharyngeal masses with suspicion of nasopharyngeal carcinoma in adult patients]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018; 53:519-523. [PMID: 30032495 DOI: 10.3760/cma.j.issn.1673-0860.2018.07.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To improve the accuracy of diagnosis and to reduce the misdiagnosis rate of nasopharyngeal carcinoma by analyzing the characteristics of such masses. Methods: Clinical data from 55 patients with suspicion of nasopharyngeal carcinoma diagnosed and treated between March 2016 and September 2017 were analyzed. All patients were followed up regularly. Results: With following-up of 12 to 25 months, 6 (10.9%) of 55 cases were identified as nasopharyngeal malignant tumors, including 4 cases of nasopharyngeal carcinoma and 2 cases of lymphoma, and 49 cases (89.1%) were diagnosed with nasopharyngeal benign masses, including 29 (59.2%) cases for nasopharyngeal lymphoid proliferation, 15 (30.6%) for adenoid hypertrophy, 2 (4.1%) for nasopharyngeal cyst, 1 (2.0%) for polyp, 1 for papilloma and 1 for nasopharyngeal pharyngeal cyst. Small nasopharyngeal malignant tumor and masses with benign hyperplasia showed the overlap of images on the enhanced MRI/CT and Fibro-nasopharyngoscopy, but all 6 patients with nasopharyngeal malignant tumors presented with moderately enhanced multiple enlarged lymph nodes. Conclusions: Fibro-nasopharyngoscopy and enhanced MRI/CT have some value on evaluation of nasopharyngeal masses, but biopsy is a golden standard for diagnosis. Follow-up is necessary for the patients with negative biopsy and benign nasopharyngeal hyperplasia indicated by fibro-nasopharyngoscopy and enhanced MRI/CT.
Collapse
Affiliation(s)
- X J Yan
- Department of Otorhinolaryngology Head and Neck Surgery, Guangyuan Central Hospital Affiliated to North Sichuan Medical College, Guangyuan 628000, Sichuan, China
| | - S Fang
- Department of Otorhinolaryngology Head and Neck Surgery, Guangyuan Central Hospital Affiliated to North Sichuan Medical College, Guangyuan 628000, Sichuan, China
| | - G W Huang
- Department of Otorhinolaryngology Head and Neck Surgery, PLA General Hospital, Beijing 100853, China
| | - J Wang
- Department of Otorhinolaryngology Head and Neck Surgery, PLA General Hospital, Beijing 100853, China
| | - K L Xu
- Department of Otorhinolaryngology Head and Neck Surgery, Guangyuan Central Hospital Affiliated to North Sichuan Medical College, Guangyuan 628000, Sichuan, China
| | - X X Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, PLA General Hospital, Beijing 100853, China
| |
Collapse
|
24
|
Chai WM, Ou-Yang C, Huang Q, Lin MZ, Wang YX, Xu KL, Huang WY, Pang DD. Antityrosinase and antioxidant properties of mung bean seed proanthocyanidins: Novel insights into the inhibitory mechanism. Food Chem 2018; 260:27-36. [PMID: 29699669 DOI: 10.1016/j.foodchem.2018.04.001] [Citation(s) in RCA: 46] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Revised: 03/08/2018] [Accepted: 04/01/2018] [Indexed: 12/31/2022]
Abstract
This study investigated the structure, antioxidant activity, antityrosinase activity and mechanism of proanthocyanidins from mung bean seed [Vigna radiata (L.) Wilczek]. The structural composition were characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), electrospray ionization-full-mass spectrometry (ESI-Full-MS), and high-pressure liquid chromatography-electrospray ionization-mass spectrometry (HPLC-ESI-MS) techniques. The mung bean seed proanthocyanidins were composed of procyanidins, prodelphinidins, and their rhamnosides. According to enzyme kinetic analysis, these compounds were potent, reversible, and mixed-type inhibitors of tyrosinase. They inhibited the enzyme activity by interacting with enzyme as well as substrates. The results of molecular docking showed that the interaction between mung bean seed proanthocyanidins and tyrosinase was driven by hydrogen bond, hydrophobic and electrostatic interactions. In addition, mung bean seed proanthocyanidins were demonstrated as powerful antioxidants. Therefore, this study confirmed a novel tyrosinase inhibitor and would lay a scientific foundation for their utilization in pharmaceutical and food industries.
Collapse
Affiliation(s)
- Wei-Ming Chai
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China.
| | - Chong Ou-Yang
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Qian Huang
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Mei-Zhen Lin
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Ying-Xia Wang
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Kai-Li Xu
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Wen-Yang Huang
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Dan-Dan Pang
- College of Life Science and Key Laboratory of Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| |
Collapse
|
25
|
Chai WM, Huang Q, Lin MZ, Ou-Yang C, Huang WY, Wang YX, Xu KL, Feng HL. Condensed Tannins from Longan Bark as Inhibitor of Tyrosinase: Structure, Activity, and Mechanism. J Agric Food Chem 2018; 66:908-917. [PMID: 29313327 DOI: 10.1021/acs.jafc.7b05481] [Citation(s) in RCA: 80] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/18/2023]
Abstract
In this study, the content, structure, antityrosinase activity, and mechanism of longan bark condensed tannins were evaluated. The findings obtained from mass spectrometry demonstrated that longan bark condensed tannins were mixtures of procyanidins, propelargonidins, prodelphinidins, and their acyl derivatives (galloyl and p-hydroxybenzoate). The enzyme analysis indicated that these mixtures were efficient, reversible, and mixed (competitive is dominant) inhibitor of tyrosinase. What's more, the mixtures showed good inhibitions on proliferation, intracellular enzyme activity and melanogenesis of mouse melanoma cells (B16). From molecular docking, the results showed the interactions between inhibitors and tyrosinase were driven by hydrogen bond, electrostatic, and hydrophobic interactions. In addition, high levels of total phenolic and extractable condensed tannins suggested that longan bark might be a good source of tyrosinase inhibitor. This study would offer theoretical basis for the development of longan bark condensed tannins as novel food preservatives and medicines of skin diseases.
Collapse
Affiliation(s)
- Wei-Ming Chai
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University , Nanchang, Jiangxi 330022, People's Republic of China
| | - Qian Huang
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University , Nanchang, Jiangxi 330022, People's Republic of China
| | - Mei-Zhen Lin
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University , Nanchang, Jiangxi 330022, People's Republic of China
| | - Chong Ou-Yang
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University , Nanchang, Jiangxi 330022, People's Republic of China
| | - Wen-Yang Huang
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University , Nanchang, Jiangxi 330022, People's Republic of China
| | - Ying-Xia Wang
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University , Nanchang, Jiangxi 330022, People's Republic of China
| | - Kai-Li Xu
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University , Nanchang, Jiangxi 330022, People's Republic of China
| | - Hui-Ling Feng
- Zigong Innovation Center of Zhejiang University , Zigong, Sichuan 643000, China
| |
Collapse
|
26
|
Yan XJ, Xu KL, Zhang XX. [Immunotherapies for head and neck squamous cell carcinomas]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2017; 31:1050-1056. [PMID: 29798179 DOI: 10.13201/j.issn.1001-1781.2017.13.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 12/31/2016] [Indexed: 11/12/2022]
Abstract
The Head and neck squamous cell carcinoma (HNSCC) is a group of heterogeneous diseases. Patients with HNSCC demonstrate poor prognosis and survival time with standard therapy, especially in patients with advanced HNSCC. Recurrence and metastasis have not yet been effectively controlled. The immune profile in HNSCC, whether caused by carcinogen exposure or human papillomavirus (HPV), showed significantly immunosuppression. With the understanding of the complex interaction between tumor and immune system and immune escape mechanism of HNSCC, new immunotherapies have been generating. This article will summarize the immunological mechanism and immune therapy of HNSCC currently..
Collapse
|
27
|
Li W, Li MF, Zhao PP, Qiao JL, Xu KL, Zeng LY. [Effects of allogeneic hematopoietic stem cell transplantation in combination with infusion of endothelial progenitor cells on bone marrow inflammatory injury]. Zhonghua Xue Ye Xue Za Zhi 2017; 38:318-324. [PMID: 28468094 PMCID: PMC7342716 DOI: 10.3760/cma.j.issn.0253-2727.2017.04.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
目的 探索异基因造血干细胞移植联合内皮祖细胞(EPC)输注对骨髓炎性损伤的影响。 方法 6~8周龄BALB/c(H-2Kd)小鼠经致死剂量全身照射(TBI)预处理后建立异基因骨髓移植模型(BMT组),并在BMT基础上同时输注体外培养的EPC,建立骨髓联合EPC移植模型(EPC组)。移植后第7、14、21、28天分别获取各组小鼠骨髓细胞,流式细胞术检测EPC培养比率及两组嵌合率变化,通过骨髓细胞和外周血细胞计数比较两组骨髓造血情况,Western blot法检测骨髓巨噬细胞表面特异性标志CD68表达水平;实时定量PCR及Western blot法分析骨髓炎性复合体nlrp1、nlrp6、caspase-1 mRNA及蛋白表达水平。 结果 移植后第7天BMT组嵌合率为(83.69±1.26)%,明显低于EPC组的(91.65±2.77)%(P<0.05)。在移植后第10、15、20天,EPC组小鼠外周血中的WBC、网织红细胞、PLT均高于BMT组(P值均<0.05),在第7、21天EPC组骨髓中原始红细胞较BMT组高(P值均<0.05)。HE染色显示,移植后第7、14、21天,EPC组骨髓微环境恢复较BMT组快。Western blot检测显示EPC组骨髓CD68蛋白表达水平较BMT组低。EPC组nlrp1、nlrp6、casepase-1 mRNA及蛋白表达水平在移植后各时间点接近正常表达水平,与BMT组相比,差异均有统计学意义(P值均<0.05)。 结论 异基因造血干细胞移植联合输注EPC可减少炎性细胞的浸润及减少炎性复合体的活化,促进骨髓造血重建。
Collapse
Affiliation(s)
- W Li
- Blood Diseases Institute, Xuzhou Medical University, Xuzhou 221002, China
| | | | | | | | | | | |
Collapse
|
28
|
Chai WM, Lin MZ, Song FJ, Wang YX, Xu KL, Huang JX, Fu JP, Peng YY. Rifampicin as a novel tyrosinase inhibitor: Inhibitory activity and mechanism. Int J Biol Macromol 2017; 102:425-430. [PMID: 28414110 DOI: 10.1016/j.ijbiomac.2017.04.058] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2017] [Revised: 04/11/2017] [Accepted: 04/12/2017] [Indexed: 01/07/2023]
Abstract
In this study, the inhibitory effect and mechanism of rifampicin on the activity of tyrosinase were investigated for developing a novel tyrosinase inhibitor. It was found to have a significant inhibition on the activity of tyrosinase (IC50=90±0.6μM). From the kinetics analysis, it was proved to be a reversible and noncompetitive type inhibitor of the enzyme with the KI value of 94±3.5μM. The results obtained from intrinsic fluorescence quenching indicated that rifampicin could interact with tyrosinase. In particular, the drastic decrease of fluorescence intensity was due to the formation of a rifampicin-enzyme complex in a static procedure which was mainly driven by hydrophobic forces and hydrogen bonding. Moreover, the ANS-binding fluorescence analysis suggested that rifampicin binding to tyrosinase changed the polarity of the hydrophobic regions. Molecular docking analysis further revealed that the hydrogen bonds were generated between rifampicin and amino residues Leu7, Ser52, and Glu107 in the B chain of the enzyme. And the hydrophobic forces produced through the interaction of rifampicin with B chain residues Pro9, Pro14, and Trp106. This work identified a novel tyrosinase inhibitor and potentially contributed to the usage of rifampicin as a potential hyperpigmentation drug.
Collapse
Affiliation(s)
- Wei-Ming Chai
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China.
| | - Mei-Zhen Lin
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Fang-Jun Song
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Ying-Xia Wang
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Kai-Li Xu
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Jin-Xin Huang
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Jian-Ping Fu
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China
| | - Yi-Yuan Peng
- College of Life Science and Key Laboratory of Small Functional Organic Molecule, Ministry of Education, Jiangxi Normal University, Nanchang, Jiangxi 330022, China.
| |
Collapse
|
29
|
Yang ZX, Xu KL, Xiong H. Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis. Exp Ther Med 2015; 9:1363-1368. [PMID: 25780436 PMCID: PMC4353784 DOI: 10.3892/etm.2015.2256] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2014] [Accepted: 12/05/2014] [Indexed: 11/28/2022] Open
Abstract
This study aimed to analyze the clinical characteristics, classification and treatment of childhood myasthenia gravis (MG) and address the prognosis through follow-up. The clinical data of 135 children with MG were grouped according to clinical type and therapeutic drugs, retrospectively analyzed and prospectively monitored. Of the 135 MG patients, 85.2% had type I (ocular type), with only 4.2% progressing to systemic MG; 13.4% had type II (general type); and 1.5% had type III (fulminating type). Relapse occurred in 46.1% of the 102 patients that were followed up. The positive rate for the primary acetylcholine receptor antibody was 40.19%, without significant differences among clinical subtypes. The positive rate of the repetitive nerve stimulation frequency test by electromyography was 37.97%. Decreased expression of CD4+, CD8+, or CD3+ was present in 71% of the patients. Thymic hyperplasia was present in 5.93% of the patients, while 1.48% had thymoma. Steroid treatment was effective in the majority of the patients. Ocular type MG was common in this cohort of patients. The incidence and mortality of myasthenia crisis were low, the presence of concurrent thymoma was rare and only a limited number of children developed neurological sequelae.
Collapse
Affiliation(s)
- Zhi-Xiao Yang
- Department of Neurology, Children's Hospital of Zhengzhou, Zhengzhou, Henan 450053, P.R. China
| | - Kai-Li Xu
- Department of Neurology, Children's Hospital of Zhengzhou, Zhengzhou, Henan 450053, P.R. China
| | - Hui Xiong
- Department of Paediatrics, Peking University First Hospital, Beijing 100034, P.R. China
| |
Collapse
|
30
|
Deng XM, Xiao WJ, Tang GZ, Luo MP, Xu KL. Minimum local analgesic concentration of ropivacaine for intra-operative caudal analgesia in pre-school and school age children. Anaesthesia 2011; 65:991-5. [PMID: 20659102 DOI: 10.1111/j.1365-2044.2010.06454.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
We compared the minimum local analgesia concentration of ropivacaine for intra-operative caudal analgesia in pre-school and school age children. Fifty-one boys, undergoing hypospadius repair surgery, were stratified into pre-school or school age groups. After induction of anaesthesia, caudal block was performed with ropivacaine 1 ml.kg⁻¹ of the desired concentration. The first child in each group received ropivacaine 0.125%, and subsequent concentrations were determined by the analgesic response of the previous patient using Dixon's up-and-down method. Under general anaesthesia with 0.7 minimum alveolar concentration of sevoflurane, the minimum local analgesia concentration of ropivacaine for intra-operative caudal block was 34% greater in school age than in pre-school age boys (0.143% (95% CI 0.132-0.157%) vs 0.107% (95% CI 0.089-0.122%), respectively; p < 0.001). This study indicates that a higher concentration of ropivacaine is needed for school age than pre-school age children to provide intra-operative caudal analgesia when combined with general anaesthesia.
Collapse
Affiliation(s)
- X M Deng
- Department of Anaesthesiology, Plastic Surgery Hospital, Beijing, China
| | | | | | | | | |
Collapse
|
31
|
Abstract
UNLABELLED Small-dose ketamine in combination with sedative drugs has increasingly been used for sedation and analgesia in local anesthesia. We compared the clinical efficacy of midazolam with two different ketamine infusion regimens during plastic surgery under local anesthesia. Sixty patients undergoing plastic surgery procedures with local anesthesia were randomly assigned to two groups of 30 patients each in a double-blinded fashion. All patients received a bolus of 0.05 mg/kg midazolam, followed by a stepwise infusion: 1.67 microg x kg(-1) x min(-1) for the first 30 min, then reduced to 1.33 microg x kg(-1) x min(-1) for 90 min and subsequently to 1 microg x kg(-1) x min(-1). Two minutes before the infiltration of local anesthetic solution, a bolus of ketamine 0.3 mg/kg IV was administered, followed by a stepwise infusion of ketamine: Group A, 16.67 microg x kg(-1) x min(-1) for 30 min, 13.3 microg x kg(-1) x min(-1) for 90 min, and subsequently 10 microg x kg(-1) x min(-1); Group B, 8.33 microg x kg(-1) x min(-1) for 30 min, 6.67 microg x kg(-1) x min(-1) for 90 min, and then 5 microg x kg(-1) x min(-1). The level of sedation was evaluated by using the modified Observer's Assessment of Alertness/Sedation scale. We observed the effects of the two ketamine infusion regimens on sedation levels, respiratory and cardiovascular variables, and perioperative side effects. In both groups, midazolam and ketamine produced adequate sedation (with Observer's Assessment of Alertness/Sedation scores of 2-4) without significant respiratory and cardiovascular depression during surgery. However, there were fewer disruptive movements and there was less postoperative vomiting in Group B (P < 0.01). In conclusion, ketamine and midazolam provided satisfactory intraoperative sedation, analgesia, and amnesia in both groups. However, side effects associated with ketamine occurred less often in the smaller-dose ketamine group. IMPLICATIONS Sedation and analgesia are often provided during local anesthesia. This study demonstrates that a small-dose ketamine infusion in combination with midazolam provided satisfactory intraoperative sedation, analgesia, and amnesia in healthy plastic-surgery patients when it was used to supplement local anesthesia.
Collapse
Affiliation(s)
- X M Deng
- Department of Anesthesiology, Plastic Surgery Hospital, The Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
| | | | | | | | | |
Collapse
|
32
|
Sell S, Xu KL, Huff WE, Kabena LF, Harvery RB, Dunsford HA. Aflatoxin exposure produces serum alphafetoprotein elevations and marked oval cell proliferation in young male Pekin ducklings. Pathology 1998; 30:34-9. [PMID: 9534206 DOI: 10.1080/00313029800169645] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Feeding of aflatoxin to ducks produces extensive oval cell proliferation in the liver associated with a prolonged elevation of serum alphafetoprotein (AFP). Short term feeding of 0.075-0.6 microgram/g of aflatoxin to young male Pekin ducks results in rapid and massive dose-related proliferation of "oval" cells, which extend from the portal zone across the hepatic lobule within three to five weeks. Longer term feeding of 0.15 microgram/g and 0.3 microgram/g results in prolonged elevations of serum AFP. Prolonged elevation of serum AFP serves as a marker of oval cell proliferation preceding hepatocellular carcinoma (HCC) development. These results confirm that ducks are sensitive to low amounts of aflatoxin and develop early lesions that have been shown in other studies to be associated with hepatocarcinogenesis. These findings in ducks support the likelihood that aflatoxin exposure contributes to the risk for development of HCC in humans.
Collapse
Affiliation(s)
- S Sell
- Department of Pathology and Laboratory Medicine, University of Texas, College Station, USA
| | | | | | | | | | | |
Collapse
|
33
|
Xu KL, Guan SF, Shen ZZ. [Differential diagnosis of benign liver diseases from primary liver cancer with elevation of AFP shown by lentil lectin immunoelectrophoresis]. Zhonghua Nei Ke Za Zhi 1986; 25:269-71, 317. [PMID: 2427282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
34
|
Xu KL, Yu EX, Lu LN, Zhou J. Alpha-fetoprotein variants and their clinical significance. Chin Med J (Engl) 1984; 97:538-41. [PMID: 6084582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
|
35
|
Xu KL. [The plastic capillary leucocyte migration inhibition test and its clinical application (author's transl)]. Zhonghua Nei Ke Za Zhi 1980; 19:354-6. [PMID: 7227071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
36
|
Xu KL, Li ML, Guan SF, Yu EX, Song MZ, Shen YX. [Clinical analysis of low AFP level cases and their prognosis (author's transl)]. Zhonghua Zhong Liu Za Zhi 1980; 2:45-9. [PMID: 6160027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|